GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (XSGO:LLYCL) » Definitions » Shiller PE Ratio

Eli Lilly and Co (XSGO:LLYCL) Shiller PE Ratio : 119.17 (As of May. 09, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Eli Lilly and Co Shiller PE Ratio?

As of today (2025-05-09), Eli Lilly and Co's current share price is CLP727000.00. Eli Lilly and Co's E10 for the quarter that ended in Mar. 2025 was CLP6,100.28. Eli Lilly and Co's Shiller PE Ratio for today is 119.17.

The historical rank and industry rank for Eli Lilly and Co's Shiller PE Ratio or its related term are showing as below:

XSGO:LLYCL' s Shiller PE Ratio Range Over the Past 10 Years
Min: 23.03   Med: 39.69   Max: 172.05
Current: 117.23

During the past years, Eli Lilly and Co's highest Shiller PE Ratio was 172.05. The lowest was 23.03. And the median was 39.69.

XSGO:LLYCL's Shiller PE Ratio is ranked worse than
95.61% of 524 companies
in the Drug Manufacturers industry
Industry Median: 24.34 vs XSGO:LLYCL: 117.23

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Eli Lilly and Co's adjusted earnings per share data for the three months ended in Mar. 2025 was CLP2,852.923. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is CLP6,100.28 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Eli Lilly and Co Shiller PE Ratio Historical Data

The historical data trend for Eli Lilly and Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Shiller PE Ratio Chart

Eli Lilly and Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.58 63.05 74.95 115.11 126.75

Eli Lilly and Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 146.38 162.13 156.83 126.75 128.85

Competitive Comparison of Eli Lilly and Co's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Shiller PE Ratio falls into.


;
;

Eli Lilly and Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Eli Lilly and Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=727000.00/6100.28
=119.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Eli Lilly and Co's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2852.923/134.9266*134.9266
=2,852.923

Current CPI (Mar. 2025) = 134.9266.

Eli Lilly and Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 353.770 100.684 474.088
201509 518.519 100.392 696.892
201512 304.894 99.792 412.239
201603 278.928 100.470 374.586
201606 482.522 101.688 640.243
201609 487.547 101.861 645.812
201612 467.253 101.863 618.920
201703 -66.197 102.862 -86.832
201706 631.312 103.349 824.204
201709 331.788 104.136 429.892
201712 -1,003.977 104.011 -1,302.392
201803 700.765 105.290 898.018
201806 -159.380 106.317 -202.269
201809 761.798 106.507 965.074
201812 728.392 105.998 927.183
201903 2,885.949 107.251 3,630.671
201906 995.041 108.070 1,242.326
201909 984.689 108.329 1,226.451
201912 1,195.369 108.420 1,487.612
202003 1,344.529 108.902 1,665.842
202006 1,233.619 108.767 1,530.313
202009 1,028.432 109.815 1,263.607
202012 1,616.166 109.897 1,984.260
202103 1,081.894 111.754 1,306.224
202106 1,114.821 114.631 1,312.197
202109 958.150 115.734 1,117.041
202112 1,538.161 117.630 1,764.343
202203 1,676.662 121.301 1,864.999
202206 910.707 125.017 982.897
202209 1,488.677 125.227 1,603.991
202212 1,779.163 125.222 1,917.050
202303 1,203.024 127.348 1,274.619
202306 1,559.045 128.729 1,634.108
202309 -53.196 129.860 -55.272
202312 2,119.329 129.419 2,209.513
202403 2,404.828 131.776 2,462.321
202406 3,043.492 132.554 3,097.973
202409 990.691 133.029 1,004.824
202412 4,804.791 133.157 4,868.641
202503 2,852.923 134.927 2,852.923

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Eli Lilly and Co  (XSGO:LLYCL) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Eli Lilly and Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Eli Lilly and Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eli Lilly and Co Business Description

Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Eli Lilly and Co Headlines

No Headlines